Gastroenterology department operational reorganisation at the time of covid-19 outbreak: an Italian and Chinese experience
- PMID: 32299837
- DOI: 10.1136/gutjnl-2020-321143
Gastroenterology department operational reorganisation at the time of covid-19 outbreak: an Italian and Chinese experience
Erratum in
-
Correction: Gastroenterology department operational reorganisation at the time of COVID-19 outbreak: an Italian and Chinese experience.Gut. 2021 Mar;70(3):e1. doi: 10.1136/gutjnl-2020-321143corr1. Gut. 2021. PMID: 33547040 Free PMC article. No abstract available.
Keywords: IBD clinical; endoscopy.
Conflict of interest statement
Competing interests: SD has served as a speaker, consultant and advisory board member for Schering-Plough, Abbott (AbbVie) Laboratories, Merck and Co, UCB Pharma, Ferring, Cellerix, Millenium Takeda, Nycomed, Pharmacosmos, Actelion, Alfa Wasserman, Genentech, Grunenthal, Pfizer, Astra Zeneca, Novo Nordisk, Vifor and Johnson & Johnson. AA as served as Advisory board member of gilead, AbbVie, Intercept, MSD and Alfasigma. AR has served as advisory board member for Medtronic Fuijfilm, Norgine, Boston Scientific, EndoKey, EndoStart, Erbe and Alfasigma.
MeSH terms
LinkOut - more resources
Full Text Sources